Satoshi Fukata

462 total citations
33 papers, 346 citations indexed

About

Satoshi Fukata is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Satoshi Fukata has authored 33 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Satoshi Fukata's work include Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Satoshi Fukata is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Satoshi Fukata collaborates with scholars based in Japan and United States. Satoshi Fukata's co-authors include Taro Shuin, Keiji Inoue, Chiaki Yoshikawa, Masayuki Kamada, Chiaki Kawada, Taku Ohwada, Mutsuo Furihata, Yuji Ohtsuki, Pheroze Tamboli and Takashi Karashima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Journal of Computational Physics.

In The Last Decade

Satoshi Fukata

27 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Fukata Japan 10 155 124 107 83 81 33 346
Aris Ι. Giotakis Austria 11 97 0.6× 72 0.6× 129 1.2× 86 1.0× 182 2.2× 38 437
Stephen Wu United States 8 164 1.1× 80 0.6× 47 0.4× 40 0.5× 51 0.6× 10 482
Carlos Olivier Spain 10 77 0.5× 88 0.7× 116 1.1× 99 1.2× 139 1.7× 27 379
Junki Maehara Japan 8 97 0.6× 173 1.4× 61 0.6× 104 1.3× 189 2.3× 17 464
Koji Minami Japan 10 107 0.7× 75 0.6× 108 1.0× 69 0.8× 128 1.6× 38 378
Juntang Guo China 9 140 0.9× 231 1.9× 73 0.7× 57 0.7× 107 1.3× 21 397
Magdalena Bogdańska Poland 8 114 0.7× 40 0.3× 31 0.3× 104 1.3× 51 0.6× 24 312
A. Magalini Italy 9 109 0.7× 21 0.2× 61 0.6× 51 0.6× 128 1.6× 15 344
Changwen Zhai China 12 205 1.3× 60 0.5× 143 1.3× 143 1.7× 91 1.1× 22 407
Yu Ishizuya Japan 13 173 1.1× 150 1.2× 104 1.0× 154 1.9× 117 1.4× 36 402

Countries citing papers authored by Satoshi Fukata

Since Specialization
Citations

This map shows the geographic impact of Satoshi Fukata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Fukata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Fukata more than expected).

Fields of papers citing papers by Satoshi Fukata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Fukata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Fukata. The network helps show where Satoshi Fukata may publish in the future.

Co-authorship network of co-authors of Satoshi Fukata

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Fukata. A scholar is included among the top collaborators of Satoshi Fukata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Fukata. Satoshi Fukata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shimasaki, Shunichi, Erika Yamashita, Hideo Fukuhara, et al.. (2025). Successful Management of Tumor Lysis Syndrome Following Enfortumab Vedotin Plus Pembrolizumab Therapy in Metastatic Urothelial Carcinoma: A Case Report. IJU Case Reports. 8(5). 470–474.
3.
Ashida, Shingo, Hideo Fukuhara, Nobutaka Shimizu, et al.. (2024). Comprehensive genomic profiling of primary bladder mucinous adenocarcinoma, a rare genitourinary cancer: A case report. Urology Case Reports. 58. 102892–102892.
4.
Tamura, Kenji, Nobutaka Shimizu, Hideo Fukuhara, et al.. (2023). Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume. Research and Reports in Urology. Volume 15. 157–164. 2 indexed citations
5.
Karashima, Takashi, Keisuke Mizutani, Hideo Fukuhara, et al.. (2023). Primary adrenal Ewing’s sarcoma family of tumors with tumor thrombus of the inferior vena cava: a case report. Journal of Medical Case Reports. 17(1). 108–108.
6.
Fukuhara, Hideo, et al.. (2021). Successful treatment with DCF chemotherapy and radiotherapy for primary squamous cell carcinoma of the prostate. IJU Case Reports. 4(6). 421–424. 4 indexed citations
7.
Tamura, Kenji, Hideo Fukuhara, Satoshi Fukata, et al.. (2021). Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting. Urologia Internationalis. 106(10). 1005–1011.
8.
Ashida, Shingo, Ichiro Yamasaki, Chiaki Kawada, et al.. (2021). Evaluation of a rapid one-step PSA test for primary prostate cancer screening. BMC Urology. 21(1). 135–135. 2 indexed citations
9.
Karashima, Takashi, Naoto Kuroda, Hirofumi Satake, et al.. (2018). Bilateral Xp11.2 translocation renal cell carcinoma: a case report. BMC Urology. 18(1). 106–106. 6 indexed citations
10.
Karashima, Takashi, Keiko Udaka, Satoshi Fukata, et al.. (2017). Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model. Oncology Letters. 14(1). 1162–1166. 2 indexed citations
11.
Karashima, Takashi, Naoto Kuroda, Takahiro Taguchi, et al.. (2015). Chromophobe renal cell carcinoma, eosinophilic variant with papillary growth: a case report.. PubMed. 8(10). 13590–5. 1 indexed citations
12.
Kurabayashi, Atsushi, Keiji Inoue, Hideo Fukuhara, et al.. (2015). Combination with third‐generation bisphosphonate (YM529) and interferon‐alpha can inhibit the progression of established bone renal cell carcinoma. Cancer Science. 106(8). 1092–1099. 3 indexed citations
13.
Karashima, Takashi, Yoshinori Taniguchi, Hiroshi Nishikawa, et al.. (2014). IgG4-related disease of the paratestis in a patient with Wells syndrome: a case report. Diagnostic Pathology. 9(1). 225–225. 9 indexed citations
14.
Fukuhara, Hideo, Yoshinori Taniguchi, Manabu Matsumoto, et al.. (2014). IgG4-related tubulointerstitial nephritis accompanied with cystic formation. BMC Urology. 14(1). 54–54. 6 indexed citations
15.
Tamura, Kenji, Mutsuo Furihata, Hirofumi Satake, et al.. (2011). SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression. Oncology Letters. 3(2). 264–268. 20 indexed citations
16.
Inoue, Keiji, Hideo Fukuhara, Satoshi Fukata, et al.. (2009). CLINICAL EXPERIENCE WITH TRANSURETHRAL RESECTION OF BLADDER TUMOR (TUR-Bt) GUIDED BY PHOTODYNAMIC DIAGNOSIS (PDD). The Japanese Journal of Urology. 100(7). 661–670. 3 indexed citations
17.
Inoue, Keiji, Satoshi Fukata, Tatsuo Iiyama, et al.. (2007). AN EVALUATION OF THE EFFECTS OF MICROWAVE TISSUE COAGULATION, RADIOFREQUENCY ABLATION OR ULTRASONICALLY-ACTIVATED SCALPEL ON RENAL TISSUE AS A MINIMALLY INVASIVE THERAPY. The Japanese Journal of Urology. 98(7). 808–818.
18.
Fukata, Satoshi, Masayuki Kamada, Chiaki Kawada, et al.. (2005). Levels of angiogenesis and expression of angiogenesis‐related genes are prognostic for organ‐specific metastasis of renal cell carcinoma. Cancer. 103(5). 931–942. 61 indexed citations
19.
Moriki, Toshiaki, et al.. (2004). Lipoma‐like tumor mass probably arising in the retroperitoneal heterotopic pancreas: A previously undescribed lesion. Pathology International. 54(7). 527–531. 9 indexed citations
20.
Inoue, Keiji, et al.. (2002). Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.. PubMed. 8(7). 2389–98. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aris Ι. Giotakis Breakdown of academic impact, for papers by Stephen Wu Breakdown of academic impact, for papers by Carlos Olivier Breakdown of academic impact, for papers by Junki Maehara Breakdown of academic impact, for papers by Koji Minami Breakdown of academic impact, for papers by Juntang Guo Breakdown of academic impact, for papers by Magdalena Bogdańska Breakdown of academic impact, for papers by A. Magalini Breakdown of academic impact, for papers by Changwen Zhai Breakdown of academic impact, for papers by Yu Ishizuya
Rankless by CCL
2026